Source: Eur Respir Rev 2014; 23: 356-366
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Cortot Alexis B., Jänne Pasi A.. Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas. Eur Respir Rev 2014; 23: 356-366

Member's Comments

No comment yet.

Related content which might interest you: Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancer Source: Eur Respir J 2011; 37: 183-193 Year: 2011 Epidermal growth factor receptor expression in pre-invasive and early invasive bronchial lesions Source: Eur Respir J 2003; 21: 611-615 Year: 2003 Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) as a prognostic factor of survival in patients with lung adenocarcinoma Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up Source: Eur Respir J 2009; 33: 436-440 Year: 2009 Overexpression of fibroblast growth factor and down-regulation of platelet-derived growth factor correlate with advanced-stage lung fibrosis Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 Clinical features associated with epidermal growth factor receptor and K-RAS gene mutations in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 811s Year: 2006 Changes and significance of hepatoma-derived growth factor and vascular endothelial growth factor in serum and lung tissue from patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Prognostic significance of epidermal growth factor receptor expression in nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002 Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Source: Eur Respir J 2008; 32: 924-930 Year: 2008 A blood-based test for epidermal growth factor receptor mutations in patients with non-small cell lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008 Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer Source: Eur Respir J 2005; 25: 329-335 Year: 2005 Detection of epidermal growth factor receptor mutation in plasma as predictor of gefitinib response in non small cell lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008 Stage IV adenocarcinoma of the lung with classical epidermal growth factor receptor mutation and a thought-provoking course Source: Virtual Congress 2021 – Lung cancer grand round Year: 2021 Potential role of short hairpin RNA targeting epidermal growth factor receptor in growth and sensitivity to drugs of human lung adenocarcinoma cells Source: Eur Respir J 2006; 28: Suppl. 50, 325s Year: 2006 Synergistic effect of cysteinyl-leukotrienes and epidermal growth factor on human lung fibroblast mitogenesis Source: Eur Respir J 2005; 26: Suppl. 49, 340s Year: 2005 Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo Source: Eur Respir J 2011; 38: 939-946 Year: 2011 Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis Source: Eur Respir J 2013; 41: 417-424 Year: 2013 Molecular mechanisms of the synergy between cysteinyl-leukotrienes and receptor tyrosine kinase growth factors on human bronchial fibroblast proliferation Source: Eur Respir J 2006; 28: Suppl. 50, 339s Year: 2006 Molecular mechanisms of the synergy between cysteinyl-leukotrienes and receptor tyrosine kinase growth factors on human bronchial fibroblast proliferation Source: Eur Respir Rev 2006; 15: 172-174 Year: 2006